Eden Research (LON:EDEN) Shares Down 3.3% – What’s Next?

Eden Research plc (LON:EDENGet Free Report)’s share price traded down 3.3% on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The firm’s 50-day moving average is GBX 3.88 and its two-hundred day moving average is GBX 3.95. The stock has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92.

Insider Activity

In related news, insider Lykele van der Broek acquired 256,000 shares of the stock in a transaction that occurred on Thursday, February 6th. The stock was purchased at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey acquired 540,540 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Corporate insiders own 14.02% of the company’s stock.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

Read More

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.